Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian Kopp

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 14, 2021
A Guideline to Set Up Cascaded Continuous Cultivation with E. coli Bl21 (DE3)Julian Kopp, Oliver Spadiut
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2023
Inclusion Bodies: Status Quo and PerspectivesJulian Kopp, Oliver Spadiut
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2025
Adapting Komagataella phaffii Cultivation Media to REACH RegulationsJulian Kopp, Alexander Pekarsky, Oliver Spadiut
Microorganisms|June 27, 2024
Bioconversion of Furanic Compounds by <i>Chlorella vulgaris</i>-Unveiling Biotechnological PotentialsRicarda Kriechbaum, Oliver Spadiut, Julian Kopp
Applied Microbiology and Biotechnology|December 21, 2018
Perspectives of inclusion bodies for bio-based products: curse or blessing?Christoph Slouka, Julian Kopp, Oliver Spadiut, et al.
Frontiers in Bioengineering and Biotechnology|December 12, 2019
The Rocky Road From Fed-Batch to Continuous Processing With <i>E. coli</i>Julian Kopp, Christoph Slouka, Oliver Spadiut, et al.
Frontiers in Bioengineering and Biotechnology|March 25, 2025
Chances and drawbacks of derepressed recombinant enzyme production in continuous cultivations with <i>Komagataella phaffii</i>Mihail Besleaga, Katharina Ebner, Anton Glieder, et al.
Journal of Environmental Management|July 15, 2024
Towards a circular economy - Repurposing side streams from the potato processing industry by Chlorella vulgarisRicarda Kriechbaum, Laura Kronlachner, Andreas Limbeck, et al.
Drug Discovery Today. Technologies|December 13, 2021
Microbial technologies for biotherapeutics production: Key tools for advanced biopharmaceutical process development and controlDenes Zalai, Julian Kopp, Bence Kozma, et al.
Microbial Biotechnology|July 13, 2022
Fundamental insights in early-stage inclusion body formationJulian Kopp, Benjamin Bayer, Christoph Slouka, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|September 14, 2021
A Guideline to Set Up Cascaded Continuous Cultivation with E. coli Bl21 (DE3)Julian Kopp, Oliver Spadiut
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2023
Inclusion Bodies: Status Quo and PerspectivesJulian Kopp, Oliver Spadiut
Methods in Molecular Biology (Clifton, N.J.)|October 1, 2025
Adapting Komagataella phaffii Cultivation Media to REACH RegulationsJulian Kopp, Alexander Pekarsky, Oliver Spadiut
Microorganisms|June 27, 2024
Bioconversion of Furanic Compounds by <i>Chlorella vulgaris</i>-Unveiling Biotechnological PotentialsRicarda Kriechbaum, Oliver Spadiut, Julian Kopp
Applied Microbiology and Biotechnology|December 21, 2018
Perspectives of inclusion bodies for bio-based products: curse or blessing?Christoph Slouka, Julian Kopp, Oliver Spadiut, et al.
Frontiers in Bioengineering and Biotechnology|December 12, 2019
The Rocky Road From Fed-Batch to Continuous Processing With <i>E. coli</i>Julian Kopp, Christoph Slouka, Oliver Spadiut, et al.
Frontiers in Bioengineering and Biotechnology|March 25, 2025
Chances and drawbacks of derepressed recombinant enzyme production in continuous cultivations with <i>Komagataella phaffii</i>Mihail Besleaga, Katharina Ebner, Anton Glieder, et al.
Journal of Environmental Management|July 15, 2024
Towards a circular economy - Repurposing side streams from the potato processing industry by Chlorella vulgarisRicarda Kriechbaum, Laura Kronlachner, Andreas Limbeck, et al.
Drug Discovery Today. Technologies|December 13, 2021
Microbial technologies for biotherapeutics production: Key tools for advanced biopharmaceutical process development and controlDenes Zalai, Julian Kopp, Bence Kozma, et al.
Microbial Biotechnology|July 13, 2022
Fundamental insights in early-stage inclusion body formationJulian Kopp, Benjamin Bayer, Christoph Slouka, et al.
Pageof 4